ArticlePloS one2025
N-glycosylation of NANOG regulates stemness and apoptosis in colon cancer cells.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative evaluation of different MALDI-TOF-MS platforms for plasma IgG N-glycan profiling: impact on analytical performance and clinical conclusions.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the effect of N-glycosylation on NANOG regulation of colon cancer stem cell characteristics. The GEPA database was used to screen and analyze the expression of N-glycosylase in colon cancer tissues. CD133 + stem cells were selected by magnetic bead sorting of colon cancer HCT116 cells and LoVo cells. Plasmid transfection of colon cancer stem cells was performed by Lipofectamine™ 3000. Cell activity was detected by MTT method. Microsphere formation test was used to detect the diameter and number of stem cell spheres. EdU flow cytometry was used to detect cell proliferation. Scratch assay was used to detect cell migration ability. Western Blot was used to detect the expression level of apoptosis-related proteins. Compared with the control group, colon cancer stem cells transfected with mutant expression vectors with N-glycosylation site deletion had reduced cell activity, decreased proliferation and migration ability; reduced tumor stem cell sphere formation ability; and increased intracellular apoptosis level. Conclusively, The seven N-glycans in the carboxyl terminus of human NANOG are involved in the molecular quality control of NANOG protein and the maintenance of the stem cell characteristics of colon cancer stem cells, further affecting the proliferation and migration ability of colon cancer stem cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.